ORIC Pharmaceuticals, Inc.
ORIC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $50 | $76 | $49 | $59 |
| Short-Term Investments | $237 | $207 | $154 | $197 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $8 | $9 | $8 | $6 |
| Total Curr. Assets | $296 | $291 | $211 | $262 |
| Property Plant & Equip (Net) | $3 | $3 | $3 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $126 | $45 | $20 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $7 | $8 | $8 | $9 |
| Total NC Assets | $136 | $56 | $31 | $12 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $431 | $347 | $243 | $274 |
| Liabilities | – | – | – | – |
| Payables | $3 | $3 | $5 | $2 |
| Short-Term Debt | $3 | $3 | $3 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $14 | $12 | $9 | $20 |
| Total Curr. Liab. | $20 | $18 | $18 | $25 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $4 | $5 | $6 | $6 |
| Total NC Liab. | $4 | $5 | $6 | $6 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $3 | $3 | $3 | $3 |
| Total Liabilities | $24 | $23 | $23 | $31 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$662 | -$629 | -$593 | -$563 |
| AOCI | $1 | $0 | $0 | $0 |
| Other Equity | $1,068 | $953 | $812 | $806 |
| Total Equity | $407 | $324 | $220 | $243 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $431 | $347 | $243 | $274 |
| Net Debt | -$46 | -$73 | -$46 | -$56 |